Company Performance Metrics
- Christina Coughlin: Non Executive DirectorPast Role: Avacta Group, Head of Research And Development
- Francis Wilson: VP ChemistryPast Role: Summit Therapeutics, Director of Chemistry
Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. It is engaged in the research, development, production and delivery of instrumentation and services for the biopharmaceutical drug development and clinical diagnostics markets using biophysical technology. The
Company has two segments: Analytical and Animal Health. The Analytical segment provides tools and contract services for early stage protein characterisation and analysis for biopharmaceutical drug developers. The Animal Health provides tools and contract services to assist diagnosis of conditions in animals to enable faster treatment for veterinarians. The Company’s subsidiaries include Avacta Limited, Avacta Analytical Limited, Oriental Fine Foods Limited, Avacta Health Limited, TheraGenetics Limited and TheraGenetics Inc.
###Readybuy Plc acquires Avacta Ltd in a reverse merger and changed name to Avacta Group Plc in 2004. Readybuy was founded in 2003.###
